Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

raloxifene CV [Design Issues]

posted by d_labes – Berlin, Germany, 2015-07-17 10:05 (3999 d 20:05 ago) – Posting: # 15099
Views: 7,633

Hi John, hi Mauricio,

❝ Between 30 - 45%.

Confirmed if CV for Cmax is meant:
1 study pivotal 36 subj. in 2005: CV(Cmax) ~29%; CV(AUC) ~22%
1 study pilot, 12 subj. in 2010: CV(Cmax) ~41%; CV(AUC) ~ 15%

—
Regards,

Detlew

Complete thread:

raloxifene jag009 2015-07-15 16:39
- raloxifene Mauricio Sampaio 2015-07-17 00:59
  - raloxifene CVd_labes 2015-07-17 08:05
- raloxifene drgunasakaran1 2015-07-19 16:46
  - raloxifene CV jag009 2015-07-20 06:42

Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
348 visitors (0 registered, 348 guests [including 14 identified bots]).
Forum time: 06:10 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas. Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz